PHARMACOECONOMIC ANALYSIS OF THE USE OF EVEROLIMUS COMPARED TO AXITINIB IN SECOND LINE THERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA › SPbU Researchers Portal

PHARMACOECONOMIC ANALYSIS OF THE USE OF EVEROLIMUS COMPARED TO AXITINIB IN SECOND LINE THERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

Research output: Contribution to journal › Article

A Kolbin
M Frolov
A Kurylev
Y Balykina
M Proskurin

Original language	Undefined
Journal	Value in Health
Issue number	3:19-29
State	Published - 2015

ID: 5829193